Clinuvel Pharmaceuticals | CUV - Cost Of Sales

Stock Price
11.06
Daily Change
-0.67 -5.71%
Monthly
-9.79%
Yearly
-3.57%
Q1 Forecast
10.78

Clinuvel Pharmaceuticals reported AUD1.93M in Cost of Sales for its fiscal semester ending in June of 2024.





Cost Of Sales Change Date
Avita Medical AUD 3.47M 1.19M Jun/2025
Medical Developments International AUD 2.18M 3.09M Jun/2025
Mesoblast USD 19.87M 34.61M Jun/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Pacific Edge NZD 280K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 1.88K 16.84K Jun/2025
Telix Pharmaceuticals AUD 148.66M 10.4M Dec/2024